|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
19 February 2015 |
|
Main ID: |
NCT00004667 |
|
Date of registration:
|
24/02/2000 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
Phase I Study of Human Von Willebrand Factor for Von Willebrand's Disease
|
|
Scientific title:
|
|
|
Date of first enrolment:
|
October 1993 |
|
Target sample size:
|
10 |
|
Recruitment status: |
Completed |
|
URL:
|
http://clinicaltrials.gov/show/NCT00004667 |
|
Study type:
|
Interventional |
|
Study design:
|
Endpoint Classification: Safety/Efficacy Study, Primary Purpose: Treatment
|
|
Phase:
|
Phase 1
|
|
|
Contacts
|
|
Name:
|
Gilbert C. White |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
University of North Carolina |
| | |
|
Key inclusion & exclusion criteria
|
PROTOCOL ENTRY CRITERIA:
- von Willebrand's disease
Age minimum:
N/A
Age maximum:
N/A
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
Von Willebrand's Disease
|
|
Intervention(s)
|
|
Drug: von Willebrand factor
|
|
Secondary ID(s)
|
|
UNCCH-826
|
|
199/11955
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|